Top compounds associated with response to CCDC137


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.03 0.4
mRNA Rapamycin CTRPv2 pan-cancer AAC -0.028 0.4
mRNA MK 1775 CTRPv2 pan-cancer AAC 0.027 0.4
mRNA XMD11-85h GDSC1000 pan-cancer AAC -0.038 0.4
mRNA Talazoparib GDSC1000 pan-cancer AAC -0.026 0.4
mRNA AZD8055 GDSC1000 pan-cancer AAC 0.026 0.4
mRNA GSK1059615 CTRPv2 pan-cancer AAC 0.036 0.4
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.027 0.4
mRNA azacitidine CTRPv2 pan-cancer AAC -0.03 0.4
mRNA brivanib CTRPv2 pan-cancer AAC 0.028 0.4
Download CSV